{
    "name": "acetaminophen/phenyltoloxamine",
    "comment": "OTC",
    "other_names": [
        "Phenagesic",
        "AcetaGesic",
        "Lagesic",
        "PB Poly-650",
        "Flextra DS",
        "Phenylgesic",
        "Relagesic Liquid",
        "Staflex"
    ],
    "classes": [
        "Analgesics",
        "Other Combos"
    ],
    "source": "https://reference.medscape.com/drug/phenagesic-acetaminophen-phenyltoloxamine-999334",
    "pregnancy": {
        "common": [
            "Pregnancy category: C",
            "Lactation: Excreted in breast milk",
            "Pregnant or breastfeeding patients should seek advice of health professional before using OTC drugs"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: Excreted in breast milk"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to drugss or formulation components",
                "Hepatitis or severe hepatic/renal impairment"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Caution in G6PD deficiency",
                "Consumption of 3 or more alcoholic beverages/day may increase risk for liver damage (associated with acetaminophen)",
                "Do not take with other products that contain acetaminophen due to risk of additive toxicity/overdose",
                "Acetaminophen: Risk for rare, but serious skin reactions that can be fatal; these reactions include Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), and acute generalized exanthematous pustulosis (AGEP); symptoms may include skin redness, blisters and rash",
                "May cause CNS depression and impair ability to operate heavy machinery",
                "May cause hepatotoxicity in acute overdose",
                "Use caution in glaucoma, hepatic impairment, prostatic hyperplasia, respiratory disease, and renal impairment"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Angioedema",
            "percent": null
        },
        {
            "name": "Laryngeal edema",
            "percent": null
        },
        {
            "name": "Sedation",
            "percent": null
        },
        {
            "name": "Pruritic maculopapular rash",
            "percent": null
        },
        {
            "name": "Urticaria",
            "percent": null
        },
        {
            "name": "Xerostomia",
            "percent": null
        },
        {
            "name": "Agranulocytosis",
            "percent": null
        },
        {
            "name": "Leukopenia",
            "percent": null
        },
        {
            "name": "Neutropenia",
            "percent": null
        },
        {
            "name": "Pancytopenia",
            "percent": null
        },
        {
            "name": "Thrombocytopenia",
            "percent": null
        },
        {
            "name": "Thrombocytopenic purpura",
            "percent": null
        },
        {
            "name": "Hepatotoxicity",
            "percent": null
        },
        {
            "name": "Blurred vision",
            "percent": null
        },
        {
            "name": "Anaphylactoid reaction",
            "percent": null
        }
    ]
}